These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21140149)

  • 1. Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium.
    Sillankorva S; Oliveira D; Moura A; Henriques M; Faustino A; Nicolau A; Azeredo J
    Curr Microbiol; 2011 Apr; 62(4):1128-32. PubMed ID: 21140149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells.
    Møller-Olsen C; Ho SFS; Shukla RD; Feher T; Sagona AP
    Sci Rep; 2018 Dec; 8(1):17559. PubMed ID: 30510202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential.
    Sada TS; Tessema TS
    BMC Infect Dis; 2024 Mar; 24(1):310. PubMed ID: 38486152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro.
    Freitag T; Squires RA; Schmid J
    Res Vet Sci; 2008 Aug; 85(1):1-7. PubMed ID: 17959211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Characterization of Lytic Bacteriophages Active against Clinical Strains of
    Alexyuk P; Bogoyavlenskiy A; Alexyuk M; Akanova K; Moldakhanov Y; Berezin V
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.
    Fu P; Zhao Q; Shi L; Xiong Q; Ren Z; Xu H; Chai S; Xu Q; Sun X; Sang M
    Virus Res; 2021 Jan; 291():198196. PubMed ID: 33098914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficiency of using Salmonella Kentucky and Escherichia coli O119 bacteriophages in the treatment and prevention of salmonellosis and colibacillosis in broiler chickens.
    Sorour HK; Gaber AF; Hosny RA
    Lett Appl Microbiol; 2020 Oct; 71(4):345-350. PubMed ID: 32628287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics.
    Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC
    J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part I: Isolation and lytic activity estimation of bacteriophages.
    Bicalho RC; Santos TM; Gilbert RO; Caixeta LS; Teixeira LM; Bicalho ML; Machado VS
    J Dairy Sci; 2010 Jan; 93(1):93-104. PubMed ID: 20059908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.
    Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK
    Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda.
    Kazibwe G; Katami P; Alinaitwe R; Alafi S; Nanteza A; Nakavuma JL
    PLoS One; 2020; 15(12):e0239107. PubMed ID: 33320859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
    Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local bacteriophage isolates showed anti- Escherichia coli O157:H7 potency in an experimental ligated rabbit ileal loop model.
    Alam M; Akhter MZ; Yasmin M; Ahsan CR; Nessa J
    Can J Microbiol; 2011 May; 57(5):408-15. PubMed ID: 21542784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.